For CEOs and Executive Leaders
Your Board Wants AI Results. Not Another Pilot.
44.23% of new patient opportunities never convert.
That's not a marketing failure, it's revenue you already paid for, leaking through operational gaps. Patient Prism's AI recovers it.
-
30% of patient interactions are missed entirely -
63% of unbooked patients never receive a follow-up -
Patient Prism recovers this revenue, automatically, at scale
AI Enthusiasm Is Everywhere. AI Revenue Is Not.
McKinsey reports 88% of organizations use AI, but only 39% report any EBIT impact. Most AI initiatives are science projects, but boards don't fund science projects. They fund results. Patient Prism gives you a deployed, revenue-producing AI win, backed by a decade of operationalized healthcare AI, in 60 days.
The Fastest Path from "AI Strategy" to "AI Revenue"
Patient Prism doesn't just analyze data. It activates revenue. We calibrate marketing, sales, and operations simultaneously, pinpointing exactly where your organization is leaking revenue and delivering the specific next steps to recover it. No stone unturned. No interaction missed.
AI Analyzes Every Patient Interaction
"Calls, texts, voicemails, chats, web forms, online scheduling requests, every patient touchpoint across every location is analyzed by AI. No interaction goes unexamined. New vs. returning patients identified. Reasons for not booking surfaced. Staff and location performance scored. Revenue at risk quantified."
CEO Impact
Complete, enterprise-wide visibility into every patient access interaction: the operational blind spot most organizations never knew they had.
AI Recovers Lost Revenue in Near Real-Time
"When a patient interaction doesn't convert, regardless of channel, our RELO engine identifies exactly what happened, why it failed, and delivers specific recovery instructions to your team in near real-time. Missed interactions are captured by AI Voice and SMS Agents before the patient reaches a competitor."
CEO Impact
Same-store revenue growth without adding locations, headcount, or marketing spend: the purest form of EBITDA expansion.
AI Calibrates Marketing, Sales & Operations
"Patient Prism doesn't stop at analytics. Through our Client Success partnership, we pinpoint the exact next steps teams need to take across marketing, sales, and operations to move the needle on both top and bottom line. Attribution by booked appointment. Location variance analysis. Operational playbooks that drive execution."
CEO Impact
A single AI platform that aligns your entire revenue engine (marketing, sales, and operations) with board-grade data and actionable precision.
A Decade of Healthcare AI.
Operationalized.
While most companies are experimenting with AI in 2026, Patient Prism has been deploying production AI in healthcare since before GPT existed. Our models are trained on the largest proprietary dataset of patient access interactions in the industry: 300 million+ calls, texts, voicemails, chats, forms, and scheduling requests... and counting.
This is the difference between an AI vendor selling you a vision and an AI partner delivering you a financial outcome. We've done this 11,000+ times. We know what works.
60,000 patients recovered through AI-powered identification and re-engagement of lost opportunities.
What Your Board Will Ask. What You'll Be Ready to Answer.
BCG's 2026 AI Radar found that 60% of CEOs have intentionally slowed AI due to fear of errors.
Patient Prism eliminates that risk. Here's how every board-level concern is addressed:
"Where's the return?"
Every dollar recovered is traceable. CFO-auditable revenue attribution by location, by campaign, by agent. Typical ROI: 15-30x within 90 days. No ambiguity.
"What if AI makes errors?"
Our AI has been refined on 300M+ patient interactions over 10+ years. This isn't a general-purpose LLM guessing at healthcare. It's purpose-built, domain-trained, and battle-tested across every channel: calls, texts, chats, forms, voicemails. HIPAA compliant. SOC 2 certified.
"How long until we see value?"
30-60 days to measurable revenue recovery. White-glove onboarding. No infrastructure replacement. Sits on top of your existing phone systems and PMS/EHR. The platform pays for itself in 2-4 months.
"Does it work across all locations?"
Built for multi-location enterprises, whether you have 10 locations or 500. Performance segmentation goes far beyond location: slice data by region, by managerial hierarchy, by individual agent in the call center or at the front desk. Identify your top and bottom performers at every level of the organization instantly.
"Will our teams actually use it?"
Our AI creates leverage, not work. Voice and SMS Agents handle missed interactions automatically. RELO delivers specific recovery instructions to your team in near real-time. Our Client Success partnership ensures teams know exactly what to do next. Adoption isn't the barrier when the system does the heavy lifting.
"What about our existing systems?"
Phone system agnostic. Works with RingCentral, Nextiva, 8x8, Vonage, and 200+ other telephone providers. No VoIP migration required. Connects to PMS/EHR systems via open API. White-glove onboarding includes extensive support working directly with your IT and telephony teams to ensure seamless integration. Minimal IT lift.
Where Most CEOs Are Stuck
AI pilot purgatory
Endless POCs that never reach production or prove ROI
12-18 month implementation timelines
By the time it's "ready," the board has lost patience
AI spend with no financial attribution
"We're investing in AI" doesn't satisfy a CFO or a PE sponsor
Risk of getting it wrong publicly
60% of CEOs have slowed AI adoption due to fear of errors
Where Patient Prism CEOs Operate
Deployed AI producing revenue in 60 days
Not a pilot. Production. Measurable.
CFO-auditable revenue attribution
Every recovered dollar traceable to the AI platform
Board-ready AI narrative with proof
"We deployed AI. It's recovering $X million annually. Here's the math."
De-risked by 10+ years of healthcare AI
300M+ patient interactions analyzed. This isn't version one.
What CEOs and Leaders Say
Frequently Asked Questions
Companies are doubling AI spend in 2026, but fewer than 1% of executives consider their AI rollout mature. The gap between investment and results is where CEOs are most exposed. Patient Prism closes that gap faster than any other AI deployment because there is nothing to build; we have already built it, trained it on 300 million+ patient interactions, and deployed it across the largest healthcare organizations in the country. By your next quarterly board meeting, you can present an AI initiative with hard financial outcomes, not a roadmap or a pilot. The CEOs winning with AI right now are not the ones who spent 18 months building custom solutions. They are the ones who deployed proven, purpose-built AI and started showing results while their competitors were still in committee.
The CEOs who win with AI in 2026 won't be the ones who planned the longest.
They'll be the ones who deployed the fastest.
Patient Prism is production-ready AI that delivers EBITDA impact in 60 days. While your competitors are still in pilot mode, you can be presenting AI-driven revenue recovery to your board.
No long-term contract required. See your revenue impact model in your first conversation.